Correlation of Genetic Mutation With Outcomes in Children With Hereditary Spherocytosis Undergoing Partial Splenectomy: A Multicentre Study

jpedsurg.org

Hereditary Spherocytosis (HS) is a common genetic hematological disorder causing a life-long hemolytic anemia, with sequela of hemolysis. Children with severe HS commonly undergo partial or total splenectomy (PS, TS); PS confers the theoretical advantage of maintaining splenic immune function, but may be associated with regrowth, ongoing hemolysis, and need for completion splenectomy. HS can be caused by 5 different pathogenic gene variants. A rare and severe form is caused by homozygous/compound heterozygous mutations in the SPTA1 gene, coding for alpha spectrin.

jpedsurg.org shows its articles on its own site.

Read the article on jpedsurg.org ↗

Article · Jan 2025 · 1 min read

In brief

This multicentre study examines how specific genetic mutations influence surgical outcomes in children with hereditary spherocytosis who undergo partial splenectomy. The research focuses on correlating five pathogenic gene variants, particularly severe SPTA1 mutations, with postoperative results including splenic regrowth and persistent hemolysis.

Hereditary spherocytosis results from 5 different pathogenic gene variants, with SPTA1 mutations causing the most severe form.
Partial splenectomy preserves immune function but risks splenic regrowth, ongoing hemolysis, and potential need for completion splenectomy.
SPTA1 gene mutations (alpha spectrin deficiency) represent a rare, severe HS subtype requiring careful surgical planning.
Genetic mutation type may predict outcomes after partial splenectomy in pediatric HS patients.
Multicentre data correlating genotype with surgical outcomes can guide individualized treatment decisions in severe HS.

Written by the GCMD Library team from the article.

Read it at the source ↗